AMENDED AND RESTATED 10% PROMISSORY NOTETauriga Sciences, Inc. • March 5th, 2020 • Medicinal chemicals & botanical products • Puerto Rico
Company FiledMarch 5th, 2020 Industry JurisdictionThis AMENDED AND RESTATED 10% PROMISSORY NOTE is made and entered into as of February 28, 2020 by and between Tauriga Sciences, Inc., a Florida corporation (the “Company”), with its principal executive offices at ______________________________________________________________________________, and Tangiers Global, LLC (the “Investor”), a Wyoming limited liability company, with its principal executive offices at Caribe Plaza Office Building 6th Floor, Palmeras St. # 53, San Juan, PR 00901 (collectively, the “Parties”).
10% CONVERTIBLE PROMISSORY NOTE OF TAURIGA SCIENCES, INC.Tauriga Sciences, Inc. • November 12th, 2019 • Medicinal chemicals & botanical products • Puerto Rico
Company FiledNovember 12th, 2019 Industry JurisdictionThis Note is a duly authorized Convertible Promissory Note of Tauriga Sciences, Inc., a corporation duly organized and existing under the laws of the State of Florida (the “Company”), designated as the Company’s 10% Convertible Promissory Note due August 5, 2020 (“Maturity Date”) in the face amount of $137,500 (the “Note”).